GSK PLC-SPON ADR (GSK)

Company Profile

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. The company is headquartered in Brentford, Middlesex and currently employs 69,400 full-time employees. The Company’s segments include Commercial Operations and Research and Development. The company develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. The company has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. Its vaccine portfolio includes more than 20 vaccines that help protect people from a range of diseases and infections throughout their lives. Its specialty medicines include medicines for immune-mediated conditions. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease (COPD), antibiotics, and medicines for skin diseases. The firm owns camlipixant, a selective P2X3 antagonist, which is in Phase III development for the treatment of refractory chronic cough (RCC).

Company Info

GSK PLC-SPON ADR

980 Great West Road

Brentford MIDDLESEX TW8 9GS

P: 442080475000

CEO: Emma Walmsley

Employees: 69400

Website: https://www.gsk.com/